This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research
Yong Li
Cangzhou Central Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-2268-6205
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Purpose: This study investigated the effect of early higher achieved mean arterial pressure (MAP) on clinical outcomes after cardiac arrest (CA).
Methods: PubMed, ScienceDirect, Web of Science, China National Knowledge Infrastructure, and Wanfang databases were searched for relevant articles until May 2020. The meta-analysis produced pooled effect size represented by odds ratios (ORs) and corresponding 95% confidence intervals (CIs).
Results: Nine studies that enrolled 1337 participants were considered eligible for this meta-analysis. Early higher achieved MAP was associated with similar mortality (OR 0.54, 95% CI 0.26 – 1.12; p = 0.10), neurologic outcome (OR 1.30, 95% CI 0.65 – 2.58; p = 0.46), length of ICU stay (OR -0.06, 95% CI -0.31 – 0.19; p = 0.46), mechanical ventilation time (OR -0.14, 95% CI -0.90 – 0.62; p = 0.72), and bleeding (OR 0.57, 95% CI 0.23 – 1.40; p = 0.22) compared with low MAP. Sensitivity analysis demonstrated that the result was solid. No publication bias across the studies was observed using Begg's and Egger’ funnel plot plot.
Conclusion: Based on current evidence, this meta-analysis confirmed that early higher achieved MAP does not improve the clinical outcomes after CA.
REGISTRATION: (PROSPERO: CRD42020189875)
Keywords
mean arterial pressure, cardiac arrest, neurological outcomes
Figure 1
Figure 2
Figure 3
Figure 4
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 17 Aug, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Critical Care & Emergency Medicine
Learn more about our company.
This is a preprint. It has not completed peer review.
Research
Yong Li
Cangzhou Central Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-2268-6205
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 17 Aug, 2020
No community comments so far
Subject Areas
Critical Care & Emergency Medicine
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Purpose: This study investigated the effect of early higher achieved mean arterial pressure (MAP) on clinical outcomes after cardiac arrest (CA).
Methods: PubMed, ScienceDirect, Web of Science, China National Knowledge Infrastructure, and Wanfang databases were searched for relevant articles until May 2020. The meta-analysis produced pooled effect size represented by odds ratios (ORs) and corresponding 95% confidence intervals (CIs).
Results: Nine studies that enrolled 1337 participants were considered eligible for this meta-analysis. Early higher achieved MAP was associated with similar mortality (OR 0.54, 95% CI 0.26 – 1.12; p = 0.10), neurologic outcome (OR 1.30, 95% CI 0.65 – 2.58; p = 0.46), length of ICU stay (OR -0.06, 95% CI -0.31 – 0.19; p = 0.46), mechanical ventilation time (OR -0.14, 95% CI -0.90 – 0.62; p = 0.72), and bleeding (OR 0.57, 95% CI 0.23 – 1.40; p = 0.22) compared with low MAP. Sensitivity analysis demonstrated that the result was solid. No publication bias across the studies was observed using Begg's and Egger’ funnel plot plot.
Conclusion: Based on current evidence, this meta-analysis confirmed that early higher achieved MAP does not improve the clinical outcomes after CA.
REGISTRATION: (PROSPERO: CRD42020189875)
Figure 1
Figure 2
Figure 3
Figure 4
Loading...